ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

Name: ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
License: Public Domain

Washington University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic pancreatic ductal adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405139
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.